Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionCurrently marketed drug that uses Vectura's smart nebuliser delivery system
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat serious lung disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today